ROIV
Price
$30.04
Change
+$0.31 (+1.04%)
Updated
Jun 12 closing price
Capitalization
21.61B
64 days until earnings call
Intraday BUY SELL Signals
VERA
Price
$34.26
Change
+$0.61 (+1.81%)
Updated
Jun 12 closing price
Capitalization
2.46B
53 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ROIV vs VERA

Header iconROIV vs VERA Comparison
Open Charts ROIV vs VERABanner chart's image
ROIV vs VERA Comparison Chart in %
View a ticker or compare two or three
VS
ROIV vs. VERA commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROIV is a StrongBuy and VERA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2026
Stock price -- (ROIV: $30.04 vs. VERA: $34.26)
Brand notoriety: ROIV and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ROIV: 95% vs. VERA: 80%
Market capitalization -- ROIV: $21.61B vs. VERA: $2.46B
ROIV [@Biotechnology] is valued at $21.61B. VERA’s [@Biotechnology] market capitalization is $2.46B. The market cap for tickers in the [@Biotechnology] industry ranges from $112.92B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ROIV’s FA Score shows that 1 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • ROIV’s FA Score: 1 green, 4 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than VERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ROIV’s TA Score shows that 6 TA indicator(s) are bullish while VERA’s TA Score has 4 bullish TA indicator(s).

  • ROIV’s TA Score: 6 bullish, 4 bearish.
  • VERA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than VERA.

Price Growth

ROIV (@Biotechnology) experienced а +5.11% price change this week, while VERA (@Biotechnology) price change was +6.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.78%. For the same industry, the average monthly price growth was +90.18%, and the average quarterly price growth was +2050.65%.

Reported Earning Dates

ROIV is expected to report earnings on Aug 17, 2026.

VERA is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+0.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($21.6B) has a higher market cap than VERA($2.46B). ROIV YTD gains are higher at: 38.433 vs. VERA (-32.346). VERA has higher annual earnings (EBITDA): -360.87M vs. ROIV (-1.28B). ROIV has more cash in the bank: 4.29B vs. VERA (597M). VERA has less debt than ROIV: VERA (76.9M) vs ROIV (107M). ROIV has higher revenues than VERA: ROIV (8.26M) vs VERA (0).
ROIVVERAROIV / VERA
Capitalization21.6B2.46B878%
EBITDA-1.28B-360.87M355%
Gain YTD38.433-32.346-119%
P/E Ratio1.97N/A-
Revenue8.26M0-
Total Cash4.29B597M719%
Total Debt107M76.9M139%
TECHNICAL ANALYSIS
Technical Analysis
ROIVVERA
RSI
ODDS (%)
Bearish Trend 3 days ago
66%
Bullish Trend 7 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
71%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ROIV
Daily Signal:
Gain/Loss:
VERA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CHAT93.140.71
+0.77%
Roundhill Generative AI & Technology ETF
XDTE38.930.25
+0.65%
Roundhill S&P 500 0DTE Cov Cll Strat ETF
CGIC36.670.08
+0.22%
Capital Group International Cor Eq ETF
EURL46.70-0.03
-0.06%
Direxion Daily FTSE Europe Bull 3X ETF
CRCG14.32-1.91
-11.77%
Leverage Shares 2X Long CRCL Daily ETF

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+1.04%
IMVT - ROIV
65%
Loosely correlated
+2.25%
IMTX - ROIV
43%
Loosely correlated
+3.53%
AXON - ROIV
43%
Loosely correlated
-1.00%
KURA - ROIV
42%
Loosely correlated
+2.14%
ABUS - ROIV
41%
Loosely correlated
-0.70%
More